News in Brief
CDMO BioDuro acquires Molecular Response
BioDuro has acquired Molecular Response LLC and its translational oncology research platform, which includes a biobank of more than 100,000 viable tumor specimens.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs